2007 EORTC-NCI-ASCO Annual Meeting: Molecular Markers in Cancer
نویسنده
چکیده
The recent EORTC-NCI-ASCO Annual Meeting on 'Molecular Markers in Cancer' was held on 15-17 November 2007 in Brussels, Belgium. It was the largest meeting to date and marked the first year in which the American Association of Clinical Oncology (ASCO) joined in the efforts of the European Organisation for Research and Treatment of Cancer (EORTC) and the National Cancer Institute (NCI) in organizing this annual event. More than 300 clinicians, pathologists, laboratory scientists and representatives from regulatory agencies and the pharmaceutical industry came together for three days of intense discussion, debate and reflection on the latest biomarker therapeutic discoveries, strategies and clinical applications. The poster discussion sessions featured 79 research abstracts. The three most outstanding abstracts, all authored by young female researchers, were selected for presentation during the main meeting sessions. Highlights of each scientific session are presented.
منابع مشابه
A Phase 1 First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer
Purpose—TRC105 is a chimeric IgG1 monoclonal antibody that binds CD105 (endoglin). This first-in-human, phase 1, open label study assessed safety, pharmacokinetics, and antitumor activity of TRC105 in patients with advanced refractory solid tumors. Patients and Methods—Patients received escalating doses of intravenous TRC105 until disease progression or unacceptable toxicity using a standard 3 ...
متن کاملGastric Cancer
4002. 12. Dank M, Zaluski J, Barone C, et al., J Clin Oncol 2005 ASCO Annual Meeting Proceedings (2005);23:Abstract 4003. 13. Cunningham D, Rao S, Starling N, et al., J Clin Oncol 2006 ASCO Annual Meeting Proceedings (2006);24: Abstract
متن کاملGenomics in personalized cancer medicine and its impact on early drug development in China: report from the 6th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at the 50th ASCO Annual Meeting
The 6th Annual Meeting of the United States Chinese Anti-Cancer Association (USCACA) was held in conjunction with the 50th Annual Meeting of American Society of Clinical Oncology (ASCO) on May 30, 2014 in Chicago, Illinois, the United States of America. With a focus on personalized medicine, the conference featured novel approaches to investigate genomic aberrations in cancer cells and innovati...
متن کاملPharmacogenetics and other molecular targets in the management of pancreatic adenocarcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Among various abstracts presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, June 2010, four interesting abstracts focusing on pancreatic cancer merit further discussion in this post-ASCO commentary as they potentially provide insight to clinicians and hope to patients. These abstracts point to the future of pancreatic cancer management through id...
متن کامل2015 ASCO Annual Meeting Press Program to Highlight Advances in Cancer Treatment, Prevention, and Patient Care
ALEXANDRIA, Va. – The American Society of Clinical Oncology (ASCO) today announced the studies to be featured in the 2015 ASCO Annual Meeting press program. They represent advances against an array of cancers and in nearly every major area of cancer patient care, including immunotherapy, targeted treatments, surgery, radiation, cancer prevention, and innovative strategies to improve patients’ q...
متن کامل